Biomarkers are traits that doctors measure in your blood, body fluids, and tissues. Experts also call them molecular markers and signature molecules. They can be signs of conditions, diseases, normal ...

Alzheimer’s disease pathology, measured by amyloid and tau blood biomarkers, can appear in midlife and is associated with worse cognitive performance years before dementia onset.

In this interview, NewsMedical speaks with Dr. Justin Devine and Dr. Nicholas Woudberg about biomarkers, their importance for drug development, and their potential for machine learning. Dr. Justin ...

Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer’s disease have not been extensively investigated in longitudinal studies. We conducted a ...

Objective Determine the role of fluid-based biomarkers, advanced neuroimaging, genetic testing and emerging technologies in defining and assessing neurobiological recovery after sport-related ...

Using a custom-built tool to analyze the electrical activity from neurons, researchers at Brown University have identified a brain-based biomarker that could be used to predict whether mild cognitive ...

Individuals in middle age with higher levels of plasma amyloid-beta 42, amyloid-beta 40 and phosphorylated-tau 217 ...

Antibiotic overuse is a major global public health concern, particularly in the management of respiratory tract infections (RTIs), which represent one of the most common reasons for consultations in ...

Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...

Panel biomarker testing can unlock some of the mysteries of treating patients so that they experience fewer side effects, better quality of life, longer survival rates and potentially, lower costs. At ...